Table I.

 Baseline values for enrolled patients.

	Creatine	Placebo
n=	53	54
Gender	35 males, 18 females	27 males, 27 females
Age	56±10	59 ±11
ALSFRS	36±6	36±7
FVC	76.2%	78.2%
Symptom onset	1.5 years	1.9 years
Limb:Bulbar onset	2.7:1	4.4:1